293 related articles for article (PubMed ID: 19857619)
1. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
[TBL] [Abstract][Full Text] [Related]
2. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading.
Follet H; Li J; Phipps RJ; Hui S; Condon K; Burr DB
Bone; 2007 Apr; 40(4):1172-7. PubMed ID: 17240209
[TBL] [Abstract][Full Text] [Related]
3. Mice lacking thrombospondin 2 show an atypical pattern of endocortical and periosteal bone formation in response to mechanical loading.
Hankenson KD; Ausk BJ; Bain SD; Bornstein P; Gross TS; Srinivasan S
Bone; 2006 Mar; 38(3):310-6. PubMed ID: 16290255
[TBL] [Abstract][Full Text] [Related]
4. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
Iwata K; Li J; Follet H; Phipps RJ; Burr DB
Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
[TBL] [Abstract][Full Text] [Related]
6. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
[TBL] [Abstract][Full Text] [Related]
7. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
[TBL] [Abstract][Full Text] [Related]
8. Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.
Allen MR; Follet H; Khurana M; Sato M; Burr DB
Calcif Tissue Int; 2006 Oct; 79(4):255-61. PubMed ID: 17033724
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
[TBL] [Abstract][Full Text] [Related]
10. Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment.
Kim CH; Takai E; Zhou H; von Stechow D; Müller R; Dempster DW; Guo XE
J Bone Miner Res; 2003 Dec; 18(12):2116-25. PubMed ID: 14672346
[TBL] [Abstract][Full Text] [Related]
11. Low-dose estrogen treatment suppresses periosteal bone formation in response to mechanical loading.
Saxon LK; Turner CH
Bone; 2006 Dec; 39(6):1261-7. PubMed ID: 16934543
[TBL] [Abstract][Full Text] [Related]
12. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R
Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678
[TBL] [Abstract][Full Text] [Related]
13. Effect of ovariectomy on bone response to in vivo external loading.
Hagino H; Raab DM; Kimmel DB; Akhter MP; Recker RR
J Bone Miner Res; 1993 Mar; 8(3):347-57. PubMed ID: 8456589
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
15. Suppression of prostaglandin synthesis with NS-398 has different effects on endocortical and periosteal bone formation induced by mechanical loading.
Li J; Burr DB; Turner CH
Calcif Tissue Int; 2002 Apr; 70(4):320-9. PubMed ID: 12004337
[TBL] [Abstract][Full Text] [Related]
16. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
17. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin K(2) and risedronate on bone formation and resorption, osteocyte lacunar system, and porosity in the cortical bone of glucocorticoid-treated rats.
Iwamoto J; Matsumoto H; Takeda T; Sato Y; Liu X; Yeh JK
Calcif Tissue Int; 2008 Aug; 83(2):121-8. PubMed ID: 18543014
[TBL] [Abstract][Full Text] [Related]
19. Bone response to mechanical loading in adult rats with collagen-induced arthritis.
Kameyama Y; Hagino H; Okano T; Enokida M; Fukata S; Teshima R
Bone; 2004 Oct; 35(4):948-56. PubMed ID: 15454102
[TBL] [Abstract][Full Text] [Related]
20. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
